Pulmonx Cost Of Revenue vs Net Income From Continuing Ops Analysis

LUNG Stock

USD 6.79 0.37 5.76%

Pulmonx Corp financial indicator trend analysis is much more than just breaking down Pulmonx Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pulmonx Corp is a good investment. Please check the relationship between Pulmonx Corp Cost Of Revenue and its Net Income From Continuing Ops accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pulmonx Corp Cost Of Revenue account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have pay attention.

The correlation between Pulmonx Corp's Cost Of Revenue and Net Income From Continuing Ops is -0.97. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Pulmonx Corp, assuming nothing else is changed. The correlation between historical values of Pulmonx Corp's Cost Of Revenue and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Pulmonx Corp are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Cost Of Revenue i.e., Pulmonx Corp's Cost Of Revenue and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.97

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Pulmonx Corp income statement and represents the costs associated with goods and services Pulmonx Corp provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income From Continuing Ops

Most indicators from Pulmonx Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pulmonx Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.The Pulmonx Corp's current Selling General Administrative is estimated to increase to about 94.3 M, while Tax Provision is projected to decrease to roughly 339.7 K.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	3.2M	4.0M	1.9M	1.8M
Interest Income	400K	1.5M	4.8M	5.0M

Depreciation And Amortization Interest Income

Pulmonx Corp fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Inventory	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Receivables	Other Assets	Other Current Assets	Intangible Assets	Short Long Term Debt Total	Other Current Liab	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total
Total Assets		0.77	0.77	0.76	-0.8	0.65	0.96	0.55	0.85	0.13	-0.17	1.0	0.64	0.88	0.91	0.7	0.38	0.96	0.04	-0.39	0.67	-0.76	0.93	-0.5	-0.95	0.86
Total Current Liabilities	0.77		0.47	0.55	-0.99	0.78	0.63	0.86	0.95	0.44	0.14	0.75	0.83	0.77	0.74	0.87	0.35	0.83	-0.03	-0.27	0.89	-0.82	0.88	-0.37	-0.64	0.93
Total Stockholder Equity	0.77	0.47		0.99	-0.48	0.09	0.79	0.21	0.67	-0.5	0.12	0.79	0.65	0.67	0.57	0.4	0.14	0.77	-0.49	-0.06	0.39	-0.41	0.65	-0.63	-0.79	0.65
Net Tangible Assets	0.76	0.55	0.99		-0.55	0.11	0.76	0.31	0.72	-0.46	0.23	0.77	0.74	0.68	0.55	0.47	0.1	0.77	-0.54	0.02	0.46	-0.44	0.66	-0.67	-0.76	0.69
Retained Earnings	-0.8	-0.99	-0.48	-0.55		-0.78	-0.66	-0.89	-0.95	-0.44	-0.08	-0.78	-0.83	-0.79	-0.73	-0.89	-0.38	-0.84	-0.01	0.24	-0.85	0.77	-0.87	0.42	0.67	-0.92
Accounts Payable	0.65	0.78	0.09	0.11	-0.78		0.53	0.67	0.69	0.78	-0.36	0.63	0.37	0.54	0.77	0.76	0.51	0.63	0.46	-0.61	0.72	-0.82	0.78	-0.04	-0.55	0.69
Cash	0.96	0.63	0.79	0.76	-0.66	0.53		0.44	0.72	0.04	-0.21	0.97	0.54	0.79	0.87	0.52	0.25	0.85	0.1	-0.39	0.48	-0.7	0.85	-0.59	-1.0	0.7
Long Term Debt	0.55	0.86	0.21	0.31	-0.89	0.67	0.44		0.78	0.57	0.14	0.53	0.71	0.57	0.49	0.75	0.1	0.57	0.18	-0.01	0.66	-0.57	0.6	-0.41	-0.44	0.68
Inventory	0.85	0.95	0.67	0.72	-0.95	0.69	0.72	0.78		0.22	0.06	0.83	0.83	0.76	0.77	0.87	0.33	0.91	-0.16	-0.23	0.86	-0.78	0.9	-0.43	-0.73	0.96
Total Liab	0.13	0.44	-0.5	-0.46	-0.44	0.78	0.04	0.57	0.22		-0.27	0.1	0.0	0.13	0.33	0.37	0.23	0.09	0.75	-0.43	0.37	-0.48	0.29	0.25	-0.05	0.21
Short Long Term Debt	-0.17	0.14	0.12	0.23	-0.08	-0.36	-0.21	0.14	0.06	-0.27		-0.17	0.48	0.09	-0.27	-0.07	-0.4	-0.09	-0.6	0.59	0.12	0.11	-0.13	-0.26	0.21	0.07
Total Current Assets	1.0	0.75	0.79	0.77	-0.78	0.63	0.97	0.53	0.83	0.1	-0.17		0.63	0.87	0.9	0.67	0.36	0.94	0.05	-0.39	0.64	-0.75	0.92	-0.52	-0.97	0.83
Short Term Debt	0.64	0.83	0.65	0.74	-0.83	0.37	0.54	0.71	0.83	0.0	0.48	0.63		0.7	0.42	0.7	0.24	0.69	-0.43	0.08	0.63	-0.48	0.65	-0.69	-0.55	0.78
Common Stock	0.88	0.77	0.67	0.68	-0.79	0.54	0.79	0.57	0.76	0.13	0.09	0.87	0.7		0.75	0.66	0.38	0.88	-0.04	-0.25	0.69	-0.65	0.82	-0.44	-0.78	0.84
Property Plant Equipment	0.91	0.74	0.57	0.55	-0.73	0.77	0.87	0.49	0.77	0.33	-0.27	0.9	0.42	0.75		0.64	0.29	0.87	0.22	-0.56	0.75	-0.92	0.94	-0.19	-0.87	0.8
Net Receivables	0.7	0.87	0.4	0.47	-0.89	0.76	0.52	0.75	0.87	0.37	-0.07	0.67	0.7	0.66	0.64		0.4	0.78	-0.1	-0.12	0.84	-0.63	0.74	-0.29	-0.51	0.88
Other Assets	0.38	0.35	0.14	0.1	-0.38	0.51	0.25	0.1	0.33	0.23	-0.4	0.36	0.24	0.38	0.29	0.4		0.43	0.1	-0.65	0.3	-0.25	0.46	0.04	-0.27	0.42
Other Current Assets	0.96	0.83	0.77	0.77	-0.84	0.63	0.85	0.57	0.91	0.09	-0.09	0.94	0.69	0.88	0.87	0.78	0.43		-0.1	-0.34	0.8	-0.75	0.93	-0.37	-0.85	0.95
Intangible Assets	0.04	-0.03	-0.49	-0.54	-0.01	0.46	0.1	0.18	-0.16	0.75	-0.6	0.05	-0.43	-0.04	0.22	-0.1	0.1	-0.1		-0.48	-0.12	-0.19	0.05	0.26	-0.1	-0.18
Short Long Term Debt Total	-0.39	-0.27	-0.06	0.02	0.24	-0.61	-0.39	-0.01	-0.23	-0.43	0.59	-0.39	0.08	-0.25	-0.56	-0.12	-0.65	-0.34	-0.48		-0.25	0.59	-0.56	-0.22	0.44	-0.27
Other Current Liab	0.67	0.89	0.39	0.46	-0.85	0.72	0.48	0.66	0.86	0.37	0.12	0.64	0.63	0.69	0.75	0.84	0.3	0.8	-0.12	-0.25		-0.81	0.82	-0.01	-0.48	0.93
Other Liab	-0.76	-0.82	-0.41	-0.44	0.77	-0.82	-0.7	-0.57	-0.78	-0.48	0.11	-0.75	-0.48	-0.65	-0.92	-0.63	-0.25	-0.75	-0.19	0.59	-0.81		-0.92	0.12	0.73	-0.78
Property Plant And Equipment Net	0.93	0.88	0.65	0.66	-0.87	0.78	0.85	0.6	0.9	0.29	-0.13	0.92	0.65	0.82	0.94	0.74	0.46	0.93	0.05	-0.56	0.82	-0.92		-0.31	-0.87	0.91
Current Deferred Revenue	-0.5	-0.37	-0.63	-0.67	0.42	-0.04	-0.59	-0.41	-0.43	0.25	-0.26	-0.52	-0.69	-0.44	-0.19	-0.29	0.04	-0.37	0.26	-0.22	-0.01	0.12	-0.31		0.58	-0.29
Net Debt	-0.95	-0.64	-0.79	-0.76	0.67	-0.55	-1.0	-0.44	-0.73	-0.05	0.21	-0.97	-0.55	-0.78	-0.87	-0.51	-0.27	-0.85	-0.1	0.44	-0.48	0.73	-0.87	0.58		-0.7
Non Current Assets Total	0.86	0.93	0.65	0.69	-0.92	0.69	0.7	0.68	0.96	0.21	0.07	0.83	0.78	0.84	0.8	0.88	0.42	0.95	-0.18	-0.27	0.93	-0.78	0.91	-0.29	-0.7

Click cells to compare fundamentals

Pulmonx Corp Account Relationship Matchups

Pulmonx Corp fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.5M	263.7M	235.2M	193.7M	177.8M	94.3M
Total Current Liabilities	14.2M	12.5M	17.6M	18.5M	23.2M	24.3M
Total Stockholder Equity	(187.4M)	226.1M	193.2M	154.0M	118.3M	124.2M
Net Tangible Assets	(190.2M)	223.4M	190.6M	151.7M	174.4M	183.1M
Retained Earnings	(210.5M)	(242.7M)	(291.4M)	(350.3M)	(411.2M)	(390.6M)
Accounts Payable	2.7M	1.5M	1.6M	1.8M	1.5M	1.2M
Cash	14.8M	231.6M	148.5M	101.7M	83.5M	58.5M
Long Term Debt	15.0M	17.4M	17.3M	17.2M	35.1M	36.8M
Inventory	5.6M	10.7M	16.3M	14.6M	16.7M	17.6M
Total Liab	240.9M	37.6M	41.9M	39.7M	59.5M	61.4M
Total Current Assets	41.1M	250.0M	208.0M	169.0M	150.4M	83.2M
Short Term Debt	446K	4.5M	2.3M	6.5M	8.3M	8.7M
Common Stock	19K	36K	37K	38K	39K	25.0K
Property Plant Equipment	7.5M	10.5M	12.9M	5.3M	6.1M	4.1M
Net Receivables	5.9M	4.2M	6.6M	8.7M	12.1M	6.5M
Other Assets	2.1M	536K	731K	5.8M	1.0	0.95
Other Current Assets	766K	3.1M	4.8M	4.0M	3.6M	2.0M
Intangible Assets	524K	400K	277K	154K	31K	29.5K
Short Long Term Debt Total	21.8M	27.2M	26.5M	24.4M	41.4M	32.1M
Other Current Liab	10.9M	6.4M	13.4M	10.0M	13.2M	11.0M
Other Liab	43K	62K	37K	94K	84.6K	58.1K
Property Plant And Equipment Net	7.5M	10.5M	12.9M	10.5M	7.4M	9.0M
Current Deferred Revenue	173K	71K	163K	120K	104K	102.7K
Net Debt	7.0M	(204.3M)	(122.0M)	(77.3M)	(42.1M)	(44.2M)
Non Current Assets Total	12.5M	13.7M	27.2M	24.7M	27.4M	20.0M
Non Currrent Assets Other	2.1M	536K	252K	5.4M	3.2M	2.2M
Cash And Short Term Investments	28.3M	231.6M	180.0M	141.1M	117.1M	128.8M
Common Stock Total Equity	19K	36K	37K	38K	43.7K	32.3K
Common Stock Shares Outstanding	35.4M	35.7M	36.1M	37.1M	38.0M	37.2M
Liabilities And Stockholders Equity	53.5M	263.7M	235.2M	193.7M	177.8M	172.1M
Non Current Liabilities Total	226.8M	25.0M	24.4M	21.2M	36.3M	67.7M
Capital Lease Obligations	6.8M	9.9M	9.0M	7.1M	4.2M	6.8M
Other Stockholder Equity	(183.6M)	467.1M	482.9M	502.7M	526.8M	333.1M
Net Invested Capital	(172.4M)	243.5M	210.7M	171.3M	155.6M	87.1M
Property Plant And Equipment Gross	7.5M	10.5M	4.8M	4.7M	12.3M	7.3M
Accumulated Other Comprehensive Income	1.4M	1.7M	1.7M	1.6M	2.6M	1.9M
Capital Stock	19K	36K	37K	38K	39K	34.1K
Net Working Capital	26.9M	237.5M	190.5M	150.5M	127.3M	134.9M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:

How To Invest In Pulmonx

Details

Is Pulmonx Stock a good investment?

Details

What is Pulmonx Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.47)

Revenue Per Share

2.043

Quarterly Revenue Growth

0.154

Return On Assets

(0.20)

Return On Equity

(0.52)

The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pulmonx Cost Of Revenue vs Net Income From Continuing Ops Analysis

Cost Of Revenue vs Net Income From Continuing Ops

Cost Of Revenue vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Net Income From Continuing Ops

Pulmonx Corp fundamental ratios Correlations

Pulmonx Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pulmonx Corp fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.97	Cash
Cash	+ 0.96	Total Assets
Other Current Assets	+ 0.96	Total Assets
Non Current Assets Total	+ 0.96	Inventory

Net Debt	- 1.0	Cash
Retained Earnings	- 0.99	Total Current Liabilities
Net Debt	- 0.97	Total Current Assets
Inventory	- 0.95	Retained Earnings
Net Debt	- 0.95	Total Assets
Property Plant And Equipment Net	- 0.92	Other Liab